Featured Article

February 20, 2025

Where is RBQM Heading in The Future With AI?

Richard Young, Chief Strategy Officer at CluePoints, shares insights on AI and risk-based quality management (RBQM) in clinical trials. With experience at both CluePoints and Veeva, Young discusses AI’s role, transparency, and the future of risk management in clinical trials.

Guide

A Comprehensive Guide to Adaptive Site Monitoring

Blog

Leveraging RBQM In Ways You Never Envisioned

Risk-Based Quality Management (RBQM) is fast becoming a staple in clinical research, and the community is...

Blog

Risk-Based Study Execution (RBx) – It’s Time To Close The Loop!

Transforming RBQM into Proactive Quality Actions When the journey began, the focus was clear: monitoring. The...

Blog

Decoding ICH E6(R3): What It Means for Risk-Based Quality Management (RBQM)

Authors: Frederic Blais, Jelena Pasimisina, Melissa Thomas ICH E6(R3) provides greater clarity on proactively designing quality...